China Biologic Products Holdings, Inc.

Delisted

CIK 1369868fmd_02MX15N5ZHECBMJ1CFEANNGN49Manufacturing · Biological Products, (No Diagnostic Substances)Template: Standard

Coverage: Jan 01, 2009 to Dec 31, 2019, 33 periods

Income Statement · Annual · Millions · USD
Line item	FY2010	FY2011	FY2012	FY2013	FY2014	FY2015	FY2016	FY2017	FY2018	FY2019
Total revenues	140	153	185	203	243	296	341	370	467	504
Cost of revenue	37	46	59	65	80	106	124	126	147	175
Gross profit	103	107	126	138	163	190	217	245	320	329
Research and development	2	4	3	4	4	6	7	7	10	12
Operating income	69	32	74	87	111	133	144	136	146	164
Interest expense	3	5	1	1	4	2	0	1	0	1
Interest and investment income	1	1	3	4	7	6	8	8	14	21
Other non-operating income (expense)	(3)	10	7	5	12	3	10	11	20	28
Income before taxes	66	42	81	92	123	135	154	146	166	191
Income tax expense	14	11	15	16	27	21	25	64	18	28
Net income from continuing operations	52	31	66	77	96	114	129	82	148	163
Net income	32	18	45	55	71	89	105	68	128	139
Net income to common shareholders	32	18	45	54	70	87	102	66	125	137